Mark F. Bailey Sr. - 05 Nov 2024 Form 4 Insider Report for Zoomcar Holdings, Inc. (ZCAR)

Role
Director
Signature
/s/ Mark Bailey
Issuer symbol
ZCAR
Transactions as of
05 Nov 2024
Net transactions value
+$2,499,959
Form type
4
Filing time
04 Dec 2024, 16:06:48 UTC
Previous filing
04 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZCAR Common Stock Purchase $787,999 +184,112 +14% $4.28 1,534,496 05 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZCAR Pre-Funded Warrants to purchase Common Stock Purchase $1,711,960 +400,000 $4.28 400,000 05 Nov 2024 Common Stock 400,000 $0.000100 Direct F1, F5
transaction ZCAR Series A Warrants to purchase Common Stock Purchase +1,168,224 1,168,224 05 Nov 2024 Common Stock 1,168,224 $4.03 Direct F1, F2, F3
transaction ZCAR Series B Warrants to purchase Common Stock Purchase 0 0 05 Nov 2024 Common Stock 0 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Purchased at a per-unit price of $4.28 (each unit consisting of one share of common stock, two Series A Warrants and one Series B Warrant) (or in the case of Pre-Funded Warrants, the per unit price was $4.28 less $0.0001 for each Pre-Funded Warrant purchased).
F2 Subject to adjustment on the reset date.
F3 The Series A Warrants will become exercisable only after stockholder approval and will remain exercisable for a period of five years from the date that they are initially exercisable.
F4 The Series B Warrants are not exercisable for any shares initially, but upon the reset date will become exercisable for up to 2,517,625 shares of common stock, at an exercise price of $0.0001, and will remain exercisable until all Series B Warrants are exercised. The Series B Warrants will become exercisable only after stockholder approval.
F5 No expiration date.